Anumana partners with Novartis to develop AI cardiovascular disease detection tools
The partnership will focus on software that uses ECGs to find left ventricular dysfunction and atherosclerotic cardiovascular disease.
Source: mobihealthnews - Category: Information Technology Source Type: news
More News: Cardiology | Cardiovascular | Electrocardiogram | Heart | Information Technology | Partnerships